GlaxoSmithKline Finds ‘Synta’ergy With $1 Billion Deal For Oncology Candidate
This article was originally published in The Pink Sheet Daily
Executive Summary
Synta CEO tells “The Pink Sheet” DAILY deal will allow firm to move other pipeline candidates through development on its own.